Quality of life can impact PFS in ovarian cancer
The diagnosis of ovarian cancer often occurs in the late stages due to a lack of adequate screening facilities. However, it is coming to light that the patients quality of life may be just as importa...
Author: VJOncology
Added: 07/27/2018 (Source: Oncology Tube)
Source: Oncology Tube - July 27, 2018 Category: Cancer & Oncology Source Type: podcasts
Aromatase inhibitors for subfertility treatment in women with polycystic ovary syndrome
The Cochrane Gynaecology and Fertility Group has prepared more than 200 reviews and in May 2018, a team from Germany, The Netherlands and New Zealand updated one of these reviews, looking at the use of letrozole for subfertile women with anovulatory polycystic ovary syndrome. Lead author, Sebastian Franik from the University of M ünster in Germany describes the latest findings in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - June 15, 2018 Category: General Medicine Authors: Cochrane Source Type: podcasts
Stop Screening for Early Ovarian Cancer, USPSTF Says
There is no evidence that screening actually improves outcomes in ovarian cancer, according to a USPSTF analysis of the best available data. (Source: Medscape Oncology)
Source: Medscape Oncology - April 13, 2018 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Drugs for Long-Term is a New Area for Ovarian Cancer Dont give up on path inhibitors too early because of toxicity
Jonathan Ledermann, MD, professor of medical oncology, UCL Cancer Institute, London, explains how Drugs for Long-Term is a New Area for Ovarian Cancer Dont give up on path inhibitors too early because...
Author: Cancer-News
Added: 04/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 10, 2018 Category: Cancer & Oncology Source Type: podcasts
Genetic testing for breast and ovarian cancer: tackling the challenges to availability
Genetic testing is not always routinely available to breast and/or ovarian cancer patients, or those at high-risk of developing these malignancies; the question is, why? And how can these challenges b...
Author: VJOncology
Added: 04/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 9, 2018 Category: Cancer & Oncology Source Type: podcasts
Improving pathways for the genetic testing of breast and ovarian cancer
Due to advancements in genetic testing, women who have breast and/or ovarian cancer, or who are at high-risk of developing these cancers, are easier to identify. Genetic testing can also lead to the i...
Author: VJOncology
Added: 04/09/2018 (Source: Oncology Tube)
Source: Oncology Tube - April 9, 2018 Category: Cancer & Oncology Source Type: podcasts
USPSTF Recommendation: Screening for Ovarian Cancer
Interview with Michael J. Barry, MD, Task Force member and co-author of Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - February 13, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Excluding PE in Low-Risk ED Patients, Screening for Ovarian Cancer, COIs in Nutrition Research, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 13, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 13, 2018 Category: General Medicine Authors: JAMA Network Source Type: podcasts
USPSTF Recommendation: Screening for Ovarian Cancer
Interview with Michael J. Barry, MD, Task Force member and co-author of Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - February 13, 2018 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
Excluding PE in Low-Risk ED Patients, Screening for Ovarian Cancer, COIs in Nutrition Research, and more
Editor's Summary by Howard Bauchner, MD, Editor in Chief of JAMA, the Journal of the American Medical Association, for the February 13, 2018 issue (Source: JAMA: This Week's Audio Commentary)
Source: JAMA: This Week's Audio Commentary - February 13, 2018 Category: General Medicine Authors: JAMA, the Journal of the American Medical Association, and The JAMA Network Source Type: podcasts
Interventions for prevention of ovarian hyperstimulation syndrome in in vitro fertilisation cycles: an overview of Cochrane reviews
Some women who have ovarian stimulation for assisted reproduction will experience an adverse effect called ovarian hyperstimulation syndrome, or OHSS. There are several Cochrane Reviews of strategies to prevent this and a new overview in January 2017 brings together the findings from these systematic reviews. The lead author, Selma Mourad from Radboud University Medical Centre in Nijmegen in the Netherlands summarises this large evidence base in this podcast. (Source: Podcasts from The Cochrane Library)
Source: Podcasts from The Cochrane Library - November 9, 2017 Category: General Medicine Authors: Cochrane Source Type: podcasts
'Important' Progress in Gynecologic Cancers: ESMO 2017
Dr Banerjee discusses advances in ovarian and cervical cancers presented at ESMO 2017. (Source: Medscape Oncology)
Source: Medscape Oncology - October 30, 2017 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Is Immunotherapy An Option For Ovarian Cancer Patients?
Dr Jalid Sehouli, Director of the Clinic of Gynecology, Charit Campus Virchow Clinic, Berlin, speaks from ESMO 2017.
Author: patientpower
Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts
